We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	3	nsubj	_	_
have	VBP	B-VP	O	Other	###	2	have	have	VBP	VBP	_	3	aux	_	_
detected	VBN	I-VP	O	Other	###	3	detected	detected	VBN	VBN	_	0	root	_	_
a	DT	B-NP	O	Other	###	4	a	a	DT	DT	_	7	det	_	_
more	RBR	I-NP	O	Other	###	5	more	more	RBR	RBR	_	6	advmod	_	_
pronounced	JJ	I-NP	O	Other	###	6	pronounced	pronounced	JJ	JJ	_	7	amod	_	_
production	NN	I-NP	O	Other	###	7	production	production	NN	NN	_	3	dobj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	9	IL-17	IL-17	NN	NN	_	7	nmod	_	_
from	IN	B-PP	O	Other	###	10	from	from	IN	IN	_	12	case	_	_
RA	NN	B-NP	O	Other	###	11	RA	RA	NN	NN	_	12	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	12	PBMC	PBMC	NN	NN	_	7	nmod	_	_
in	IN	B-PP	O	Other	###	13	in	in	IN	IN	_	16	case	_	_
response	NN	I-PP	O	Other	###	14	response	response	NN	NN	_	7	nmod	_	_
to	TO	I-PP	O	Other	###	15	to	to	TO	TO	_	16	case	_	_
IL-15	NN	B-NP	B-protein	B-Protein	###	16	IL-15	IL-15	NN	NN	_	7	nmod	_	_
and	CC	I-NP	O	Other	###	17	and	and	CC	CC	_	16	cc	_	_
MCP-1	NN	I-NP	B-protein	B-Protein	###	18	MCP-1	MCP-1	NN	NN	_	16	conj	_	_
as	RB	B-CONJP	O	Other	###	19	as	as	RB	RB	_	7	cc	_	_
well	RB	I-CONJP	O	Other	###	20	well	well	RB	RB	_	19	mwe	_	_
as	IN	I-CONJP	O	Other	###	21	as	as	IN	IN	_	19	mwe	_	_
stimulation	NN	B-NP	O	Other	###	22	stimulation	stimulation	NN	NN	_	7	conj	_	_
by	IN	B-PP	O	Other	###	23	by	by	IN	IN	_	24	case	_	_
anti-CD3	NN	B-NP	O	Other	###	24	anti-CD3	anti-CD3	NN	NN	_	22	nmod	_	_
/	/	O	O	Other	###	25	/	/	/	/	_	24	punct	_	_
anti	NN	B-NP	O	Other	###	26	anti	anti	NN	NN	_	24	dep	_	_
-	-	O	O	Other	###	27	-	-	-	-	_	26	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	28	CD28	CD28	NN	NN	_	26	dep	_	_
.	.	O	O	Other	###	29	.	.	.	.	_	3	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	4	nsubj	_	_
have	VBP	B-VP	O	Other	###	2	have	have	VBP	VBP	_	4	aux	_	_
also	RB	I-VP	O	Other	###	3	also	also	RB	RB	_	4	advmod	_	_
shown	VBN	I-VP	O	Other	###	4	shown	shown	VBN	VBN	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	5	that	that	IN	IN	_	20	mark	_	_
upregulation	NN	B-NP	O	Other	###	6	upregulation	upregulation	NN	NN	_	20	nsubj	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	8	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	8	IL-17	IL-17	NN	NN	_	6	nmod	_	_
by	IN	B-PP	O	Other	###	9	by	by	IN	IN	_	12	case	_	_
activated	VBN	B-NP	B-cell_type	Other	###	10	activated	activated	VBN	VBN	_	12	amod	_	_
T	NN	I-NP	I-cell_type	Other	###	11	T	T	NN	NN	_	12	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	12	cells	cells	NNS	NNS	_	6	nmod	_	_
in	IN	B-PP	O	Other	###	13	in	in	IN	IN	_	14	case	_	_
patients	NNS	B-NP	O	Other	###	14	patients	patients	NNS	NNS	_	12	nmod	_	_
with	IN	B-PP	O	Other	###	15	with	with	IN	IN	_	16	case	_	_
RA	NN	B-NP	O	Other	###	16	RA	RA	NN	NN	_	14	nmod	_	_
could	MD	B-VP	O	Other	###	17	could	could	MD	MD	_	20	aux	_	_
be	VB	I-VP	O	Other	###	18	be	be	VB	VB	_	20	cop	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	20	det	_	_
result	NN	I-NP	O	Other	###	20	result	result	NN	NN	_	4	ccomp	_	_
of	IN	B-PP	O	Other	###	21	of	of	IN	IN	_	22	case	_	_
activation	NN	B-NP	O	Other	###	22	activation	activation	NN	NN	_	20	nmod	_	_
via	IN	B-PP	O	Other	###	23	via	via	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	###	24	the	the	DT	DT	_	28	det	_	_
PI3K	NN	B-NP	O	Other	###	25	PI3K	PI3K	NN	NN	_	28	compound	_	_
/	/	O	O	Other	###	26	/	/	/	/	_	28	punct	_	_
Akt	NN	B-NP	B-protein	B-Protein	###	27	Akt	Akt	NN	NN	_	28	compound	_	_
pathway	NN	I-NP	O	Other	###	28	pathway	pathway	NN	NN	_	22	nmod	_	_
with	IN	B-PP	O	Other	###	29	with	with	IN	IN	_	32	case	_	_
resultant	JJ	B-NP	O	Other	###	30	resultant	resultant	JJ	JJ	_	32	amod	_	_
NF-kappaB	NN	I-NP	B-protein	Other	###	31	NF-kappaB	NF-kappaB	NN	NN	_	32	compound	_	_
activation	NN	I-NP	O	Other	###	32	activation	activation	NN	NN	_	28	nmod	_	_
.	.	O	O	Other	###	33	.	.	.	.	_	4	punct	_	_

Our	PRP$	B-NP	O	Other	###	1	Our	Our	PRP$	PRP$	_	2	nmod:poss	_	_
data	NNS	I-NP	O	Other	###	2	data	data	NNS	NNS	_	3	nsubj	_	_
provide	VBP	B-VP	O	Other	###	3	provide	provide	VBP	VBP	_	0	root	_	_
insights	NNS	B-NP	O	Other	###	4	insights	insights	NNS	NNS	_	3	dobj	_	_
into	IN	B-PP	O	Other	###	5	into	into	IN	IN	_	7	case	_	_
cellular	JJ	B-NP	O	Other	###	6	cellular	cellular	JJ	JJ	_	7	amod	_	_
mechanisms	NNS	I-NP	O	Other	###	7	mechanisms	mechanisms	NNS	NNS	_	4	nmod	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	10	det	_	_
regulation	NN	I-NP	O	Other	###	10	regulation	regulation	NN	NN	_	7	nmod	_	_
of	IN	B-PP	O	Other	###	11	of	of	IN	IN	_	13	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	12	IL-17	IL-17	NN	NN	_	13	compound	_	_
production	NN	I-NP	O	Other	###	13	production	production	NN	NN	_	10	nmod	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	15	case	_	_
RA	NN	B-NP	O	Other	###	15	RA	RA	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	###	16	,	,	,	,	_	3	punct	_	_
and	CC	O	O	Other	###	17	and	and	CC	CC	_	3	cc	_	_
highlight	VBP	B-VP	O	Other	###	18	highlight	highlight	VBP	VBP	_	3	conj	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	20	det	_	_
role	NN	I-NP	O	Other	###	20	role	role	NN	NN	_	18	dobj	_	_
of	IN	B-PP	O	Other	###	21	of	of	IN	IN	_	23	case	_	_
T	NN	B-NP	B-cell_type	Other	###	22	T	T	NN	NN	_	23	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	23	cells	cells	NNS	NNS	_	20	nmod	_	_
,	,	O	O	Other	###	24	,	,	,	,	_	23	punct	_	_
which	WDT	B-NP	O	Other	###	25	which	which	WDT	WDT	_	29	nsubjpass	_	_
has	VBZ	B-VP	O	Other	###	26	has	has	VBZ	VBZ	_	29	aux	_	_
hitherto	RB	I-VP	O	Other	###	27	hitherto	hitherto	RB	RB	_	29	advmod	_	_
been	VBN	I-VP	O	Other	###	28	been	been	VBN	VBN	_	29	auxpass	_	_
neglected	VBN	I-VP	O	Other	###	29	neglected	neglected	VBN	VBN	_	23	acl:relcl	_	_
in	IN	B-PP	O	Other	###	30	in	in	IN	IN	_	32	case	_	_
RA	NN	B-NP	O	Other	###	31	RA	RA	NN	NN	_	32	compound	_	_
pathogenesis	NN	I-NP	O	Other	###	32	pathogenesis	pathogenesis	NN	NN	_	29	nmod	_	_
.	.	O	O	Other	###	33	.	.	.	.	_	3	punct	_	_

Together	RB	B-ADVP	O	Other	###	1	Together	Together	RB	RB	_	19	advmod	_	_
with	IN	B-PP	O	Other	###	2	with	with	IN	IN	_	4	case	_	_
recent	JJ	B-NP	O	Other	###	3	recent	recent	JJ	JJ	_	4	amod	_	_
data	NNS	I-NP	O	Other	###	4	data	data	NNS	NNS	_	19	nmod	_	_
on	IN	B-PP	O	Other	###	5	on	on	IN	IN	_	8	case	_	_
the	DT	B-NP	O	Other	###	6	the	the	DT	DT	_	8	det	_	_
successful	JJ	I-NP	O	Other	###	7	successful	successful	JJ	JJ	_	8	amod	_	_
introduction	NN	I-NP	O	Other	###	8	introduction	introduction	NN	NN	_	4	nmod	_	_
of	IN	B-PP	O	Other	###	9	of	of	IN	IN	_	10	case	_	_
anti	NN	B-NP	O	Other	###	10	anti	anti	NN	NN	_	8	nmod	_	_
-	-	O	O	Other	###	11	-	-	-	-	_	10	punct	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	12	IL-17	IL-17	NN	NN	_	10	dep	_	_
in	IN	B-PP	O	Other	###	13	in	in	IN	IN	_	14	case	_	_
RA	NN	B-NP	O	Other	###	14	RA	RA	NN	NN	_	8	nmod	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	19	punct	_	_
our	PRP$	B-NP	O	Other	###	16	our	our	PRP$	PRP$	_	17	nmod:poss	_	_
results	NNS	I-NP	O	Other	###	17	results	results	NNS	NNS	_	19	nsubj	_	_
have	VBP	B-VP	O	Other	###	18	have	have	VBP	VBP	_	19	aux	_	_
added	VBN	I-VP	O	Other	###	19	added	added	VBN	VBN	_	0	root	_	_
information	NN	B-NP	O	Other	###	20	information	information	NN	NN	_	19	dobj	_	_
for	IN	B-PP	O	Other	###	21	for	for	IN	IN	_	25	case	_	_
the	DT	B-NP	O	Other	###	22	the	the	DT	DT	_	25	det	_	_
future	JJ	I-NP	O	Other	###	23	future	future	JJ	JJ	_	25	amod	_	_
molecular	JJ	I-NP	O	Other	###	24	molecular	molecular	JJ	JJ	_	25	amod	_	_
targeting	NN	I-NP	O	Other	###	25	targeting	targeting	NN	NN	_	20	nmod	_	_
of	IN	B-PP	O	Other	###	26	of	of	IN	IN	_	29	case	_	_
new	JJ	B-NP	O	Other	###	27	new	new	JJ	JJ	_	29	amod	_	_
therapeutic	JJ	I-NP	O	Other	###	28	therapeutic	therapeutic	JJ	JJ	_	29	amod	_	_
applications	NNS	I-NP	O	Other	###	29	applications	applications	NNS	NNS	_	25	nmod	_	_
in	IN	B-PP	O	Other	###	30	in	in	IN	IN	_	31	case	_	_
RA	NN	B-NP	O	Other	###	31	RA	RA	NN	NN	_	29	nmod	_	_
.	.	O	O	Other	###	32	.	.	.	.	_	19	punct	_	_

